FindTrial
Sign In

Use of blood glucose and hemoglobin for identification of thalassemia in type 2 diabetes mellitus

Utility of fasting plasma glucose-to- HBA1c ratio to detect G6PD deficiency and thalassemia in patients of type 2 diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/038078
Enrollment
200
Registered
2021-11-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E115- Type 2 diabetes mellitus with circulatory complications

Interventions

None listed

Sponsors

Dholariya Sagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All cases with type 2 diabetes mellitus above the age of 18 years and age matched apparently healthy controls will be included in study. All subjects will be undergoing interview by using questionnaires.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fasting glucose (FPG)/HbA1c ratio may be higher in DM patients with G6PD deficiency or thalassemia.Timepoint: At baseline—

Secondary

MeasureTime frame
To identify the prevalence of G6PD, thalassemia and other Hb variants in patients of T2DM.Timepoint: 3 years—

Countries

India

Contacts

Public ContactDHOLARIYA SAGAR JAYANTILAL

All India Institute of Medical sciences, Rajkot

drsagar.dholariya@gmail.com9428282513

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026